Conference Call to be held on March 4, 2013 at 8:30 a.m. EST
Combination Adds Rapidly Growing Minimally Invasive Spinal Decompression Technology
and Large Surgeon User Base
Baxano Shareholders Commit $15.3M in Concurrent Financing
RALEIGH, NC — (GLOBE NEWSWIRE) – March 4, 2013 – TranS1 Inc. (NASDAQ:TSON), a medical device company focused on designing, developing and marketing products to treat degenerative conditions of the spine affecting the lumbar region, today announced that it has entered into a definitive agreement to acquire Baxano, Inc., a privately-held medical device company that manufactures and markets the iO-Flex® system utilized in standard spinal decompression surgery and is developing the iO-Tome™ system, a precision facetectomy instrument.